HomeCompareCO vs ORCC

CO vs ORCC: Dividend Comparison 2026

CO yields 2.68% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CO wins by $2.3K in total portfolio value· pulled ahead in Year 4
10 years
CO
CO
● Live price
2.68%
Share price
$2.99
Annual div
$0.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.7K
Annual income
$318.26
Full CO calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — CO vs ORCC

📍 CO pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CO + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CO pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CO
Annual income on $10K today (after 15% tax)
$227.61/yr
After 10yr DRIP, annual income (after tax)
$270.52/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, CO beats the other by $269.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CO + ORCC for your $10,000?

CO: 50%ORCC: 50%
100% ORCC50/50100% CO
Portfolio after 10yr
$22.6K
Annual income
$159.65/yr
Blended yield
0.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

CO
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Altman Z
6.6
Piotroski
8/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CO buys
0
ORCC buys
0
No recent congressional trades found for CO or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOORCC
Forward yield2.68%9.79%
Annual dividend / share$0.08$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$23.7K$21.4K
Annual income after 10y$318.26$1.04
Total dividends collected$2.9K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: CO vs ORCC ($10,000, DRIP)

YearCO PortfolioCO Income/yrORCC PortfolioORCC Income/yrGap
1$10,968$267.77$11,190$489.61$222.00ORCC
2$12,010$274.47$12,229$256.01$219.00ORCC
3$13,132$280.89$13,216$130.74$84.00ORCC
4← crossover$14,338$287.03$14,207$66.02+$131.00CO
5$15,634$292.90$15,234$33.17+$400.00CO
6$17,027$298.49$16,317$16.62+$710.00CO
7$18,523$303.82$17,468$8.32+$1.1KCO
8$20,128$308.88$18,695$4.16+$1.4KCO
9$21,851$313.70$20,006$2.08+$1.8KCO
10$23,699$318.26$21,407$1.04+$2.3KCO

CO vs ORCC: Complete Analysis 2026

COStock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Full CO Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this CO vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CO vs SCHDCO vs JEPICO vs OCO vs KOCO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.